This inventor holds 1 USPTO granted patent. Top assignee: Iowa State University Research Foundation Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Kimberly K Buhman: Innovator in Cholesterol Management
Introduction
Kimberly K Buhman is a prominent inventor based in West Lafayette, IN (US). She has made significant contributions to the field of health and nutrition, particularly in the management of cholesterol levels. Her innovative approach focuses on the use of microorganisms to improve human health.
Latest Patents
Kimberly K Buhman holds a patent for a method titled "Oral administration of coprostanol producing microorganisms to humans." This method aims to decrease plasma cholesterol by administering coprostanol-producing bacteria to humans. Once these microorganisms reach the small intestine, they convert free cholesterol into coprostanol, which is poorly absorbed by the body. This innovative method includes pharmaceutical compositions for delivery and various methods of administration, such as incorporating the microorganisms into food.
Career Highlights
Buhman is associated with the Iowa State University Research Foundation Inc., where she continues her research and development efforts. Her work has the potential to impact dietary practices and improve cardiovascular health for many individuals.
Collaborations
She has collaborated with notable colleagues, including Donald C Beitz and Jerry W Young, who have contributed to her research endeavors.
Conclusion
Kimberly K Buhman's innovative work in cholesterol management through the use of microorganisms showcases her dedication to improving human health. Her contributions are paving the way for new dietary solutions and advancements in nutritional science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile